Literature DB >> 28662847

Calreticulin mutations and their importance in Budd-Chiari syndrome.

Abhinav Jain1, Pratik Tibdewal1, Akash Shukla2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28662847     DOI： 10.1016/j.jhep.2017.06.017

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  3 in total

1.  Budd-Chiari syndrome: consensus guidance of the Asian Pacific Association for the study of the liver (APASL).

Authors:  Akash Shukla; Ananta Shreshtha; Amar Mukund; Chhagan Bihari; C E Eapen; Guohong Han; Hemant Deshmukh; Ian Homer Y Cua; Cosmas Rinaldi Adithya Lesmana; Mamun Al Meshtab; Masayoshi Kage; Roongruedee Chaiteeraki; Sombat Treeprasertsuk; Suprabhat Giri; Sundeep Punamiya; Valerie Paradis; Xingshun Qi; Yasuhiko Sugawara; Zaigham Abbas; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2021-07-08       Impact factor: 6.047

2.  Detecting CALR Mutations in Splanchnic Vein Thrombosis: Who and How?

Authors:  Stephen E Langabeer
Journal:  J Transl Int Med       Date:  2018-06-26

Review 3.  An Update on the Management of Budd-Chiari Syndrome.

Authors:  A Sharma; S N Keshava; A Eapen; E Elias; C E Eapen
Journal:  Dig Dis Sci       Date:  2020-07-20       Impact factor: 3.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.